Bioactives

At Thermo Scientific, our compound collections—including bioactive molecules, antibiotics, and signal transduction molecules—are widely used across multiple phases of development. These libraries have been applied in both broad, exploratory studies and in highly targeted assays designed to probe specific pathways or disease mechanisms.

Rather than relying solely on large-scale, high-throughput screening campaigns, modern drug discovery increasingly adopts strategic compound selection—using smaller, curated libraries with known bioactivity or target relevance. This quality-over-quantity approach helps reduce costs, minimize false positives, and improve translational outcomes.

These molecules play a crucial role in developing therapeutics for oncology, where pathway-specific inhibitors are used to block tumor proliferation; for cardiovascular disease, where ion channel modulators and vasodilators are under investigation; in anti-infectives, where novel antibiotics address rising resistance; and for neurological disorders, where small molecules help elucidate complex neurochemical pathways and modulate neuronal function.

Whether you're mapping a signaling cascade, validating a novel drug target, or refining a lead compound, our small molecule tools are designed to provide high-impact data and accelerate decision-making across the full continuum of discovery and development.